Cargando…

Visual acuity and contrast sensitivity are two important factors affecting vision-related quality of life in advanced age-related macular degeneration

PURPOSE: Vision loss from age-related macular degeneration (AMD) has a profound effect on vision-related quality of life (VRQoL). The pupose of this study is to identify clinical factors associated with VRQoL using the Rasch- calibrated NEI VFQ-25 scales in bilateral advanced AMD patients. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roh, Miin, Selivanova, Alexandra, Shin, Hyun Joon, Miller, Joan W., Jackson, Mary Lou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944956/ https://www.ncbi.nlm.nih.gov/pubmed/29746512 http://dx.doi.org/10.1371/journal.pone.0196481

Ejemplares similares

Correlation of macular sensitivity measures and visual acuity to vision-related quality of life in patients with age-related macular degeneration
por: Forshaw, Thomas Richard Johansen, et al.
Publicado: (2021)

Functional Visual Acuity in Age-Related Macular Degeneration
por: Tomita, Yohei, et al.
Publicado: (2016)

Mental health and visual acuity in patients with age-related macular degeneration
por: Fonteh, Cheryl N., et al.
Publicado: (2022)

Photobiomodulation reduces drusen volume and improves visual acuity and contrast sensitivity in dry age‐related macular degeneration
por: Merry, Graham F., et al.
Publicado: (2016)

Relationships of orientation discrimination threshold and visual acuity with macular lesions in age-related macular degeneration
por: Fu, Haojie, et al.
Publicado: (2017)

Effect of Phacoemulsification on Visual Acuity and Macular Morphology in Patients with Wet Age-Related Macular Degeneration
por: Figurska, Małgorzata, et al.
Publicado: (2018)

Relevance of Visual Acuity Measurement for Therapeutic Decisions in Age-Related Macular Degeneration
por: Mathis, Thibaud, et al.
Publicado: (2023)

Modelling Cost Effectiveness in Neovascular Age-Related Macular Degeneration: The Impact of Using Contrast Sensitivity vs. Visual Acuity
por: Butt, Thomas, et al.
Publicado: (2014)

Relationship Between Rod-Mediated Sensitivity, Low-Luminance Visual Acuity, and Night Vision Questionnaire in Age-Related Macular Degeneration
por: McGuinness, Myra B., et al.
Publicado: (2020)

Baseline Predictors of Visual Acuity Outcome in Patients with Wet Age-Related Macular Degeneration
por: Zhang, Xinyuan, et al.
Publicado: (2018)

Bevacizumab Injection in Patients with Age-Related Macular Degeneration Associated with Poor Initial Visual Acuity
por: El Matri, Leila, et al.
Publicado: (2012)

Intravitreal treatment in patients with exudative age-related macular degeneration and visual acuity ≤ 0.05
por: Koch, Raphael, et al.
Publicado: (2015)

Visual acuity loss associated with excessive “dry macula” in exudative age-related macular degeneration
por: Takahashi, Hidenori, et al.
Publicado: (2018)

Predictors of Visual Acuity After Treatment of Neovascular Age-Related Macular Degeneration – Current Perspectives
por: Phan, Long T, et al.
Publicado: (2021)

Association of Vision-related Quality of Life with Visual Function in Age-Related Macular Degeneration
por: Pondorfer, Susanne G., et al.
Publicado: (2019)

The effects of ranibizumab injections on fluorescein angiographic findings and visual acuity recovery in age-related macular degeneration
por: Gungel, Hulya, et al.
Publicado: (2014)

Correlation of Baseline Visual Acuity with Outcomes of Treatment with Anti-VEGF in Neovascular Age-Related Macular Degeneration
por: Veluswamy, Balaji, et al.
Publicado: (2020)

Dry Age-Related Macular Degeneration: Distribution of Visual Acuity and Progression Risk in a Large Registry
por: Leng, Theodore, et al.
Publicado: (2022)

Efficacy of a single injection of brolucizumab in neovascular age-related macular degeneration on visual acuity and micromorphometry
por: Joshi, Shrinivas, et al.
Publicado: (2023)

Quantification of relative afferent pupillary defect by an automated pupillometer and its relationship with visual acuity and dimensions of macular lesions in age-related macular degeneration
por: Rajan, Renu P, et al.
Publicado: (2021)

Is the high contrast visual acuity chart a good predictor of improvement in visual acuity with low vision aids?
por: Sahu, Anupam, et al.
Publicado: (2021)

Is perceived social support more important than visual acuity for clinical depression and anxiety in patients with age-related macular degeneration and diabetic retinopathy?
por: Hernández-Moreno, Laura, et al.
Publicado: (2021)

Correlation of Central Versus Peripheral Macular Structure-Function With Acuity in Age-Related Macular Degeneration
por: Sabeti, Faran, et al.
Publicado: (2021)

Functional outcomes after multiple treatments with ranibizumab in neovascular age-related macular degeneration beyond visual acuity
por: Feigl, Beatrix, et al.
Publicado: (2007)

Benefits of aflibercept treatment for age-related macular degeneration patients with good best-corrected visual acuity at baseline
por: Minami, Sakiko, et al.
Publicado: (2018)

Foveal threshold and photoreceptor integrity for prediction of visual acuity after intravitreal aflibercept on age-related macular degeneration
por: Sakai, Tsutomu, et al.
Publicado: (2018)

Association between visual acuity, lesion activity markers and retreatment decisions in neovascular age-related macular degeneration
por: Chakravarthy, Usha, et al.
Publicado: (2020)

Five-Year Outcome of Aflibercept Monotherapy for Exudative Age-Related Macular Degeneration with Good Baseline Visual Acuity
por: Kikushima, Wataru, et al.
Publicado: (2021)

Predictive value of pigment epithelial detachment markers for visual acuity outcomes in neovascular age-related macular degeneration
por: Shu, Yiyang, et al.
Publicado: (2023)

FUSION regimen: ranibizumab in treatment-naïve patients with exudative age-related macular degeneration and relatively good baseline visual acuity
por: Monés, Jordi, et al.
Publicado: (2012)

A real-world study assessing the impact of retinal fluid on visual acuity outcomes in patients with neovascular age-related macular degeneration in Korea
por: Kim, Jae Hui, et al.
Publicado: (2022)

Neovascular Age‐Related Macular Degeneration: A Visual Acuity Model of Natural Disease Progression and Ranibizumab Treatment Effect
por: Mulyukov, Zufar, et al.
Publicado: (2018)

Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration
por: Abbas, Abdallah, et al.
Publicado: (2022)

Neuroprotection for Age-Related Macular Degeneration
por: Lin, Jonathan B., et al.
Publicado: (2022)

The Effect of Treatment Discontinuation During the COVID-19 Pandemic on Visual Acuity in Exudative Neovascular Age-Related Macular Degeneration: 1-Year Results
por: Stattin, Martin, et al.
Publicado: (2021)

Low-vision intervention in individuals with age-related macular degeneration
por: Gopalakrishnan, Sarika, et al.
Publicado: (2020)

Intraocular vision-improving devices in age-related macular degeneration
por: Grzybowski, Andrzej, et al.
Publicado: (2020)

Key drivers of visual acuity gains in neovascular age-related macular degeneration in real life: findings from the AURA study
por: Holz, Frank G, et al.
Publicado: (2016)

Intravitreal aflibercept for exudative age-related macular degeneration with good visual acuity: 2-year results of a prospective study
por: Sakamoto, Shinichi, et al.
Publicado: (2018)

Correlation between improvement in visual acuity and QOL after Ranibizumab treatment for age-related macular degeneration patients: QUATRO study
por: Oshima, Yuji, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sh6o6e4ns0i37sq9pdcqn3m8mb